View of PHARMACOKINETIC OPTIMIZATION AND TOXICITY MITIGATION OF CARDIAC GLYCOSIDES: THERAPEUTIC DRUG MONITORING OF DIGOXIN IN CHRONIC HEART FAILURE WITH ATRIAL FIBRILLATION

Return to Article Details PHARMACOKINETIC OPTIMIZATION AND TOXICITY MITIGATION OF CARDIAC GLYCOSIDES: THERAPEUTIC DRUG MONITORING OF DIGOXIN IN CHRONIC HEART FAILURE WITH ATRIAL FIBRILLATION Download Download PDF